Futura Medical (LON:FUM) Trading Up 9.1% – Here’s Why

Futura Medical plc (LON:FUM) shot up 9.1% during trading on Tuesday . The company traded as high as GBX 0.68 and last traded at GBX 0.60. 869,398 shares were traded during mid-day trading, a decline of 86% from the average session volume of 6,093,403 shares. The stock had previously closed at GBX 0.55.

Futura Medical Trading Up 9.1%

The firm has a 50-day simple moving average of GBX 0.88 and a two-hundred day simple moving average of GBX 1.10. The company has a market capitalization of £3.49 million, a price-to-earnings ratio of -0.22 and a beta of 0.01.

Futura Medical (LON:FUM) last released its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. The firm had revenue of GBX 170 million during the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. On average, sell-side analysts forecast that Futura Medical plc will post 2.8486672 earnings per share for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.